Pharmacologic agents are often used in the antepartum period, however, studies on their effect on fetal development are limited. Thus, this study aims to examine the effect of commonly prescribed antepartum medications on the development of orofacial clefting.
Methods
Utilizing EPIC Cosmos deidentified data from approximately 180 US institutions was queried. Patients born between January 1, 2013, to January 1, 2023, were included. Eight OC cohorts were identified. Gestational medication use was identified by medications prescribed, provider-administered, or reported use by mothers. Medications used in at least 1 in 10,000 pregnancies were included in this analysis.
Results
A total of 12 098 newborns with available maternal pharmacologic data were born with any type of orofacial clefting. Prevalence for all oral clefts, any cleft palate, and any cleft lip were 20.56, 18.10, and 10.60 per 10 000 individuals, respectively. Notable significant exposures include most anticonvulsants, such as lamotrigine (OR1.33, CI 1.10-1.62), and topiramate (OR1.35, CI 1.13-1.62), as well as nearly all SSRIs/SNRIs, including fluoxetine (OR1.34, CI 1.19-1.51), sertraline (OR1.25, CI 1.16-1.34), and citalopram (OR1.28, CI 1.11-1.47). Corticosteroids were also correlated including dexamethasone (OR1.19, CI 1.12-1.27), and betamethasone (OR1.64, CI 1.55-1.73), as were antibiotics, including amoxicillin (OR1.22, CI 1.14-1.30), doxycycline (OR1.29, CI 1.10-1.52), and nitrofuran derivatives (OR1.10, CI 1.03-1.17).
Conclusion
New associations between commonly prescribed antepartum medications and orofacial clefting were found. These findings should be confirmed as causality is not assessed in this report. Practitioners should be aware of the potential increased risk associated with these medications.
BernheimNGeorgesMMalevezCDe MeyAMansbachA.. Embryology and epidemiology of cleft lip and palate. B-ENT. 2006;2:11–19.
2.
MaiCTIsenburgJLCanfieldMA, et al.National population-based estimates for major birth defects, 2010-2014. Birth Defects Res. 2019;111(18):1420-1435. doi:https://doi.org/10.1002/bdr2.1589
3.
DongXLandfordWNHartJ, et al.Toward microsurgical correction of cleft lip ex utero through restoration of craniofacial developmental programs. Plast Reconstr Surg. 2017;140(1):75-85. doi:https://doi.org/10.1097/PRS.0000000000003417
AdamMPPolifkaJEFriedmanJM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011;157(3):175-182. doi:https://doi.org/10.1002/ajmg.c.30313
6.
KällínB. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate-Craniofac J. 2003;40(6):624-628. doi:https://doi.org/10.1597/02-077
7.
Van GelderMMHJDe Jong-Van Den BergLTWRoeleveldN. Drugs associated with teratogenic mechanisms. Part II: A literature review of the evidence on human risks. Hum Reprod.2014;29(1):168-183. doi:https://doi.org/10.1093/humrep/det370
8.
TarabichiYFreesAHoneywellS, et al.The Cosmos collaborative: A vendor-facilitated electronic health record data aggregation platform. ACI open. 2021;05(01):e36-e46. doi:https://doi.org/10.1055/s-0041-1731004
9.
BenjaminiYHochbergY. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B . 1995;57(1):289-300. doi:https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
10.
AltmanDGBlandJM. How to obtain the confidence interval from a P value. BMJ (Online). 2011;:343:d2090. doi:https://doi.org/10.1136/bmj.d2090
11.
SaadANParinaRPTokinCChangDCGosmanA. Incidence of oral clefts among different ethnicities in the state of California. Ann Plast Surg. 2014;72(SUPPL. 1):S81-S83. doi:https://doi.org/10.1097/SAP.0000000000000164
12.
DubovickyMBelovicovaKCsatlosovaKBogiE. Risks of using SSRI / SNRI antidepressants during pregnancy and lactation. Interdiscip Toxicol. 2017;10(1):30-34. doi:https://doi.org/10.1515/intox-2017-0004
13.
ChanJNatekarAEinarsonAKorenG. Risks of untreated depression in pregnancy. Can Fam Phy. 2014;60(3):242–243.
AndersonKNLindJNSimeoneRM, et al.Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. JAMA Psychiatry. 2020;77(12):1246. doi:https://doi.org/10.1001/jamapsychiatry.2020.2453
16.
BérardALevinMSadlerTHealyD. Selective serotonin reuptake inhibitor use during pregnancy and Major malformations: The importance of serotonin for embryonic development and the effect of serotonin inhibition on the occurrence of malformations. Bioelectricity. 2019;1(1):18-29. doi:https://doi.org/10.1089/bioe.2018.0003
17.
GedzelmanEMeadorKJ. Antiepileptic drugs in women with epilepsy during pregnancy. Ther Adv Drug Saf. 2012;3(2):71-87. doi:https://doi.org/10.1177/2042098611433192
18.
HolmesLBBaldwinEJSmithCR, et al.Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology. 2008;70(22 Pt 2):2152-2158. doi:https://doi.org/10.1212/01.wnl.0000304343.45104.d6
19.
DolkHWangHLoaneM, et al.Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology. 2016;86(18):1716-1725. doi:https://doi.org/10.1212/WNL.0000000000002540
20.
Hernández-DíazSLevinM. Alteration of bioelectrically-controlled processes in the embryo: A teratogenic mechanism for anticonvulsants. Reprod Toxicol.2014;47:111-114. doi:https://doi.org/10.1016/j.reprotox.2014.04.008
TaylorLGBirdSTSahinL, et al.Antiemetic use among pregnant women in the United States: The escalating use of ondansetron. Pharmacoepidemiol Drug Saf. 2017;26(5):592-596. doi:https://doi.org/10.1002/pds.4185
23.
HuybrechtsKFHernández-DíazSStraubL, et al.Association of maternal first-trimester ondansetron use with cardiac malformations and oral clefts in offspring. JAMA J Am Med Assoc. 2018;320(23):2429. doi:https://doi.org/10.1001/jama.2018.18307
24.
AnderkaMMitchellAALouikCWerlerMMHernández-DiazSRasmussenSA. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012;94(1):22-30. doi:https://doi.org/10.1002/bdra.22865
25.
FejzoMSMacGibbonKWMullinPM. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Reprod Toxicol.2016;62:87-91. doi:https://doi.org/10.1016/j.reprotox.2016.04.027
26.
DanielssonBWebsterWSRitchieHE. Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade. Reprod Toxicol.2018;81:237-245. doi:https://doi.org/10.1016/j.reprotox.2018.08.018
27.
FejzoMSTrovikJGrootenIJ, et al.Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019;5(1). doi:https://doi.org/10.1038/s41572-019-0110-3
28.
HammondNLDixonMJ. Revisiting the embryogenesis of lip and palate development. Oral Dis. 2022;28(5):1306-1326. doi:https://doi.org/10.1111/odi.14174
29.
PradatPRobert-GnansiaEDi TannaGL, et al.First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol. 2003;67(12):968-970. doi:https://doi.org/10.1002/bdra.10134
30.
HviidAMølgaard-NielsenD. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ Can Med Assoc J. 2011;183(7):796-804. doi:https://doi.org/10.1503/cmaj.101063
31.
CarmichaelSLShawGMMaCWerlerMMRasmussenSALammerEJ. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197(6):585.e1-585.e7. doi:https://doi.org/10.1016/j.ajog.2007.05.046
DanielssonBRDanielssonCNilssonMF. Embryonic cardiac arrhythmia and generation of reactive oxygen species: Common teratogenic mechanism for IKr blocking drugs. Reprod Toxicol.2007;24(1):42-56. doi:https://doi.org/10.1016/j.reprotox.2007.04.005
36.
Mølgaard-NielsenDHviidA. Maternal use of antibiotics and the risk of orofacial clefts: A nationwide cohort study. Pharmacoepidemiol Drug Saf. 2012;21(3):246-253. doi:https://doi.org/10.1002/pds.2179
37.
HoneinMARasmussenSAReefhuisJ, et al.Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology. 2007;18(2):226-233. doi:https://doi.org/10.1097/01.ede.0000254430.61294.c0
38.
CriderKSClevesMAReefhuisJBerryRJHobbsCAHuDJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2009;163(11). doi:https://doi.org/10.1001/archpediatrics.2009.188
39.
FasunlaAJOgunbosiBOOdaiboGN, et al.Cleft palate in HIV-exposed newborns of mothers on highly active antiretroviral therapy. Oral Surg. 2014;7(S1):102-106. doi:https://doi.org/10.1111/ors.12117
40.
CartsosVMPalaskaPKZavrasAI. Antiretroviral prophylaxis and the risk of cleft lip and palate: Preliminary signal detection in the food and drug administration’s adverse events reporting system database. Cleft Palate-Craniofac J. 2012;49(1):118-121. doi:https://doi.org/10.1597/10-095
41.
BatemanBTHernandez-DiazSStraubL, et al.Association of first trimester prescription opioid use with congenital malformations in the offspring: Population based cohort study. The BMJ. 2021;372:n102. doi:https://doi.org/10.1136/bmj.n102
42.
BroussardCSRasmussenSAReefhuisJ, et al.Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4):314.e1-314.e11. doi:https://doi.org/10.1016/j.ajog.2010.12.039
43.
XiaoWLLiuXYLiuYSZhangDZXueLF. The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis. Reprod Toxicol.2017;69:99-105. doi:https://doi.org/10.1016/j.reprotox.2017.02.006
44.
Nasiraei-MoghadamSKazeminezhadBDargahiLAhmadianiA. Maternal oral consumption of morphine increases bax/bcl-2 ratio and caspase 3 activity during early neural system development in rat embryos. J Mol Neurosci.2010;41(1):156 doi:https://doi.org/10.1007/s12031-009-9312-6
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
